diclofenac has been researched along with Facial Pain in 11 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effect of topical treatment with pregabalin and diclofenac on neuropathic orofacial pain induced by infraorbital nerve injury in the rat." | 7.78 | Topical pregabalin and diclofenac for the treatment of neuropathic orofacial pain in rats. ( Benoliel, R; Eliav, E; Heir, G; Khan, J; Markman, S; Noma, N; Patel, J; Plaza-Villegas, F, 2012) |
| "The present study was planned to evaluate the role of curcumin in the formalin-induced orofacial pain in rats that mimics typical human orofacial pain." | 7.75 | Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. ( Chakrabarti, A; Hota, D; Joshi, R; Mittal, N, 2009) |
| "The present study evaluates the possible role of dihydropyridine calcium channel antagonist nimodipine on diclofenac analgesia in formalin-induced facial pain model in rats." | 7.72 | Potentiation of antihyperalgesic activity of diclofenac by nimodipine in a formalin model of facial pain in rats. ( Hota, D; Pandhi, P, 2004) |
| " This study was designed to investigate the effects of local peripheral (into upper lip) and systemic injection of vitamin B12 and diclofenac on the orofacial pain." | 3.80 | Systemic and local peripheral injections of vitamin B12 suppressed orofacial nociception induced by formalin in rats. ( Dabbaghi, M; Erfanparast, A; Escort, M; Kazemi-Shojaei, S; Maroufi, S; Taati, M; Tamaddonfard, E, 2014) |
| "The aim of this study was to evaluate the effect of topical treatment with pregabalin and diclofenac on neuropathic orofacial pain induced by infraorbital nerve injury in the rat." | 3.78 | Topical pregabalin and diclofenac for the treatment of neuropathic orofacial pain in rats. ( Benoliel, R; Eliav, E; Heir, G; Khan, J; Markman, S; Noma, N; Patel, J; Plaza-Villegas, F, 2012) |
| "The present study was planned to evaluate the role of curcumin in the formalin-induced orofacial pain in rats that mimics typical human orofacial pain." | 3.75 | Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. ( Chakrabarti, A; Hota, D; Joshi, R; Mittal, N, 2009) |
| "The present study evaluates the possible role of dihydropyridine calcium channel antagonist nimodipine on diclofenac analgesia in formalin-induced facial pain model in rats." | 3.72 | Potentiation of antihyperalgesic activity of diclofenac by nimodipine in a formalin model of facial pain in rats. ( Hota, D; Pandhi, P, 2004) |
| "5 mg) vs paracetamol (500 mg) and placebo given in a flexible dosage regimen to treat pain resulting from extraction of impacted third molar teeth." | 2.71 | Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain. ( Gold, MS; Ionescu, E; Kubitzek, F; Liu, JM; Ziegler, G, 2003) |
| "Understanding mechanisms of neuropathic orofacial pain, targets of treatment, and basic pharmacology and working with informed compounding pharmacists may result in significant benefit for patients." | 2.49 | Topical medications as treatment of neuropathic orofacial pain. ( Heir, GM; Khan, J; Nasri-Heir, C, 2013) |
| "However, their role in orofacial pain is not clearly understood." | 1.33 | Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats. ( Kulkarni, SK; Naidu, PS; Padi, SS, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasri-Heir, C | 1 |
| Khan, J | 2 |
| Heir, GM | 1 |
| Erfanparast, A | 1 |
| Escort, M | 1 |
| Tamaddonfard, E | 1 |
| Maroufi, S | 1 |
| Kazemi-Shojaei, S | 1 |
| Dabbaghi, M | 1 |
| Taati, M | 1 |
| Saraghi, M | 1 |
| Hersh, EV | 1 |
| Mittal, N | 1 |
| Joshi, R | 1 |
| Hota, D | 2 |
| Chakrabarti, A | 1 |
| Capuano, A | 1 |
| De Corato, A | 1 |
| Treglia, M | 1 |
| Tringali, G | 1 |
| Dello Russo, C | 1 |
| Navarra, P | 1 |
| Bruno, MB | 1 |
| Bruno, MA | 1 |
| Krymchantowski, AV | 1 |
| da Motta, AF | 1 |
| Mucha, JN | 1 |
| Plaza-Villegas, F | 1 |
| Heir, G | 1 |
| Markman, S | 1 |
| Noma, N | 1 |
| Benoliel, R | 1 |
| Patel, J | 1 |
| Eliav, E | 1 |
| Kubitzek, F | 1 |
| Ziegler, G | 1 |
| Gold, MS | 1 |
| Liu, JM | 1 |
| Ionescu, E | 1 |
| Pandhi, P | 1 |
| Padi, SS | 1 |
| Naidu, PS | 1 |
| Kulkarni, SK | 1 |
| Gustov, AV | 1 |
| Sigrianskiĭ, KI | 1 |
1 review available for diclofenac and Facial Pain
| Article | Year |
|---|---|
Topical medications as treatment of neuropathic orofacial pain.
Topics: Administration, Cutaneous; Capsaicin; Cyclooxygenase Inhibitors; Diclofenac; Facial Pain; Humans; Li | 2013 |
2 trials available for diclofenac and Facial Pain
| Article | Year |
|---|---|
A double-blind, randomized clinical trial assessing the effects of a single dose of preemptive anti-inflammatory treatment in orthodontic pain.
Topics: Administration, Oral; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Facial Pain; Ort | 2011 |
Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammatory Agents, Non- | 2003 |
8 other studies available for diclofenac and Facial Pain
| Article | Year |
|---|---|
Systemic and local peripheral injections of vitamin B12 suppressed orofacial nociception induced by formalin in rats.
Topics: Animals; Diclofenac; Facial Pain; Formaldehyde; Injections, Subcutaneous; Male; Nociception; Rats; R | 2014 |
Three newly approved analgesics: an update.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Cyclooxygenase Inhibitors | 2013 |
Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Diclofenac; Dose-Response Re | 2009 |
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, | 2009 |
Topical pregabalin and diclofenac for the treatment of neuropathic orofacial pain in rats.
Topics: Administration, Topical; Analysis of Variance; Animals; Diclofenac; Facial Pain; gamma-Aminobutyric | 2012 |
Potentiation of antihyperalgesic activity of diclofenac by nimodipine in a formalin model of facial pain in rats.
Topics: Animals; Calcium Channel Blockers; Diclofenac; Disease Models, Animal; Dose-Response Relationship, D | 2004 |
Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac; Dose-Response Relati | 2006 |
[Diklovit relief of vertebrogenic and myofacial pain syndromes in lumbar space]].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Facial Pain; Female; Humans; Low Back Pa | 2001 |